__NUXT_JSONP__("/drugs/Olverembatinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1257628-77-5",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable inhibitor of a variety of kinases, including the Bcr-Abl tyrosine kinase, the mast\u002Fstem cell growth factor receptor Kit (c-Kit), the serine\u002Fthreonine protein kinase Akt (protein kinase B), and the extracellular signal-regulated kinase (ERK) with antineoplastic activity. Upon administration,olverembatinib targets, binds to and inhibits the kinase activities of Bcr-Abl, AKT, c-Kit and ERK. This inhibits their mediated signaling pathways and inhibits proliferation of tumor cells in which these kinases are overexpressed and\u002For mutated. Bcr-Abl, c-Kit, AKT and ERK play key roles in the proliferation, differentiation and survival of tumor cells.",fdaUniiCode:"KV1M7Q3CBP",identifier:"C165549",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C155700","C155764","C159198"],synonyms:["BCR-ABL\u002FKIT\u002FAKT\u002FERK Inhibitor HQP1351","GZD-824","HQP 1351","HQP-1351","HQP1351","Multi-kinase Inhibitor HQP1351","OLVEREMBATINIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FOlverembatinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Olverembatinib","","2021-10-30T13:35:45.013Z")));